Petershill Partners
Investment company From Wikipedia, the free encyclopedia
Petershill Partners is a British investment company specialising in alternative investments. Investors in the business are able to participate, through minority investments, in the profits of large private equity and hedge funds.[2] It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[3]
Company type | Public |
---|---|
Industry | Private Equity |
Founded | 2007 |
Headquarters | , |
Key people | Naguib Kheraj (Chairman) |
Products | Alternative investments |
AUM | $8.5 billion (2021)[1] |
Website | www |
History
The company was established by Goldman Sachs in 2007.[4] Between its inception and its initial public offering (IPO) in September 2021, it raised and invested US$8.5 billion in funds.[1] However, in the immediate aftermath of its IPO the company lost nearly 10% of its value.[5]
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.